Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine
AIDS Research and Human Retroviruses. Vol.26, No.6 (2010), 609-611
Suggested Citation
Weerawat Manosuthi, David M. Butler, Wasun Chantratita, Chonlaphat Sukasem, Douglas D. Richman, Davey M. Smith Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine. AIDS Research and Human Retroviruses. Vol.26, No.6 (2010), 609-611. doi:10.1089/aid.2009.0107 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/29232
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine
